Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
<1
EC/CAS
64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
N/A
General Information
Revision date
2020-10-13
Product name
KEY QNo ndusirineme]
Manufacturer Name
Krylon Products Group
Emergency telephone
(216) 566-2902, (800) 424-9300
Icons in SDS
Company Information
company name
Krylon Products Group
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H304, H317, H335, H336, H351, H373
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Aspiration hazard
Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 41.5% (oral), 41.5% (dermal), 41.5% (inhalation)
Signal word
Danger revision 10/13/2020 Date of previous issue 1 6/29/2020 Version 16 VG K00530327 KRYLON® Industrial Enamel SHW-85-NA-GHS-US
Hazard statements
Flammable liquid and vapor. May be fatal if swallowed and enters airways. ! May cause an allergic skin reaction. May cause respiratory irritation. May cause drowsiness or dizziness. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Use explosion-proof electrical, ventilating or lighting equipment. Use non-sparking tools. Take action to prevent static discharges. Use only outdoors or well-ventilated area. Do not breathe vapor. Contaminated work clothing must not in a be allowed out of the workplace.
Response
IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. IF SWALLOWED: Immediately call a POISON CENTER or doctor. Do NOT induce vomiting. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. Wash contaminated clothing before Get reuse. IF ON SKIN: Wash with plenty of water. If skin irritation or rash occurs: medical advice or attention.
Storage
closed. Keep : Store locked up. Store in a well-ventilated place. Keep container tightly cool.
Disposal
local, regional, national and : Dispose of contents and container in accordance with all international regulations.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which system damage. Intentional misuse by can cause permanent brain and nervous deliberately concentrating and inhaling the contents can be harmful or fatal. WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. FOR INDUSTRIAL USE ONLY. Please refer to the SDS for additional information. Keep out of reach of children. Do not transfer contents to other containers for storage.
2.3 Other hazards
3 residue : DANGER: Rags, steel wool, other waste soaked with this product, and sanding improperly discarded. Immediately place rags, steel may spontaneously catch fire if other waste soaked with this product, and sanding residue in a sealed, water-filled, wool, metal container. Dispose of in accordance with local fire regulations. on ingredients |
2.1 Classification of the substance or mixture
SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 ASPIRATION HAZARD - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 41.5% (oral), 41.5% (dermal), 41.5% (inhalation)